Danish Cancer Institute/LinkedIn
Jun 12, 2025, 05:14
Sara Ambjørn Joined the Danish Cancer Institute to Advance CRISPR-Based Cancer Research
Danish Cancer Institute shared a post on LinkedIn:
“Meet the Scientists of the DCI.
Assistant Professor Sara Ambjørn is part of the Cell Signaling and Cell Cycle group, led by Professor Jakob Nilsson. She’s also taking on a central role in shaping the new basic research center here at the Danish Cancer Institute, EpiC.
Sara’s research explores how cells communicate through intricate signalling pathways – processes which are hijacked in cancer. Her work focuses on decoding the molecular language that cancer cells can use to grow, survive and evade the body’s defences.
Using cutting-edge CRISPR technologies, including base editing and large-scale CRISPR screens, Sara is able to make precise changes to the DNA – sometimes altering just a single base. This enables her to investigate how tiny genetic variations can influence protein interactions and disrupt normal cell function. By mapping these changes at scale, Sara’s work is helping to reveal critical vulnerabilities in cancer cells – with the long-term goal of identifying new targets for more effective treatments.
Welcome to the DCI Sara – we look forward to following your exciting work!”
More posts featuring Danish Cancer Institute on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 11, 2025, 21:02